• 1. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Trifluoromethylbenzenes

Exploring the Properties and Applications of 3,4-Dimethoxy-2-(trifluoromethyl)benzaldehyde (CAS No. 138490-96-7)

In the realm of organic chemistry, 3,4-Dimethoxy-2-(trifluoromethyl)benzaldehyde (CAS No. 138490-96-7) stands out as a versatile and highly functionalized aromatic aldehyde. This compound, characterized by its dimethoxy and trifluoromethyl substituents, has garnered significant attention in pharmaceutical and agrochemical research. Its unique structural features make it a valuable intermediate in the synthesis of complex molecules, particularly those targeting drug discovery and crop protection applications.

The 3,4-Dimethoxy-2-(trifluoromethyl)benzaldehyde molecule combines electron-donating methoxy groups with an electron-withdrawing trifluoromethyl group, creating a distinct electronic profile. This balance of substituents influences its reactivity, making it a sought-after building block for heterocyclic chemistry and medicinal chemistry projects. Researchers frequently explore its potential in creating novel bioactive compounds, especially in the development of central nervous system (CNS) agents and anti-inflammatory drugs.

Recent trends in green chemistry have sparked interest in optimizing the synthesis of 3,4-Dimethoxy-2-(trifluoromethyl)benzaldehyde. Many laboratories now focus on developing catalyst-free or solvent-free routes to produce this compound, addressing growing concerns about environmental sustainability in chemical manufacturing. These advancements align with the pharmaceutical industry's push toward greener synthetic methodologies while maintaining high yields and purity standards.

The compound's fluorinated aromatic structure contributes to its growing importance in PET radiopharmaceuticals development. With increasing demand for diagnostic imaging agents, researchers are investigating how the trifluoromethyl group in 3,4-Dimethoxy-2-(trifluoromethyl)benzaldehyde can be leveraged to create novel molecular probes for neurological disorders. This application has become particularly relevant given the rising global prevalence of neurodegenerative diseases.

In material science, the unique electronic properties of 3,4-Dimethoxy-2-(trifluoromethyl)benzaldehyde have shown promise for developing organic electronic materials. Its ability to influence charge transport characteristics makes it interesting for OLED technology and organic semiconductors. As the electronics industry seeks more sustainable alternatives to conventional materials, this compound's potential in flexible electronics continues to be explored.

Quality control remains paramount when working with 3,4-Dimethoxy-2-(trifluoromethyl)benzaldehyde. Analytical techniques such as HPLC, GC-MS, and NMR spectroscopy are essential for verifying the compound's purity and structure. The pharmaceutical industry particularly emphasizes ICH guidelines for impurities control, making thorough characterization critical for regulatory compliance in API synthesis.

Storage and handling of 3,4-Dimethoxy-2-(trifluoromethyl)benzaldehyde require attention to its aldehyde functionality, which can be sensitive to oxidation. Best practices recommend storage under inert atmosphere at controlled temperatures to maintain stability. These considerations are especially important for researchers working on long-term stability studies of drug candidates incorporating this structural motif.

The future outlook for 3,4-Dimethoxy-2-(trifluoromethyl)benzaldehyde appears promising as new applications continue to emerge. With growing interest in personalized medicine and targeted therapies, this compound's role as a versatile intermediate will likely expand. Ongoing research into its structure-activity relationships may unlock additional therapeutic possibilities, particularly in areas like oncology and infectious diseases where fluorinated compounds have demonstrated significant potential.

• 1214384-89-0(3-Methoxy-2-(trifluoromethyl)benzaldehyde)
• 1214384-93-6(3-Methoxy-2-(trifluoromethyl)benzoic acid)
• 106312-36-1(4-Methoxy-2-(trifluoromethyl)benzaldehyde)
• 634924-69-9(Benzaldehyde, 3,4-dihydroxy-2-(trifluoromethyl)- (9CI))
• 909853-95-8(Benzaldehyde, 3-ethoxy-4-(trifluoromethyl)-)
• 180134-14-9(2-Methoxy-4,6-bis(trifluoromethyl)benzaldehyde)
• 116314-60-4(Benzaldehyde, 4-hydroxy-3-methoxy-5-(trifluoromethyl)-)
• 1017778-98-1(2-Methoxy-6-(trifluoromethyl)benzaldehyde)
• 945003-38-3(3-Methoxy-4-(trifluoromethyl)benzaldehyde)
• 1468946-11-3(4-(trifluoromethyl)-2H-1,3-benzodioxole-5-carbaldehyde)